The popular diabetes and weight-loss drug semaglutide may lower the risk of dementia when taken by Type 2 diabetes patients, new research from the Case Western Reserve School ...

As medications like 'Wegovy' and 'Ozempic' (GLP‑1 receptor agonists) become more common in weight‑loss strategies, US ...

Endocrinologist Dr Ambrish Mithal, the author of the recently-released book, The Weight Loss Revolution, talks to fitness and ...

Endocrinologist Dr Ambrish Mithal, the author of the recently-released book, The Weight Loss Revolution, talks to fitness and ...

You have been exercising, eating home-cooked meals, and have managed to cut out fried food and desserts from your diet for ...

A weight loss consultant based in Wicklow and Carlow has said that weight loss medications can never replace “the power of ...

A MOTHER has managed to shift over three stone thanks to Mounjaro, but has revealed the five things she wishes she had known ...

British Columbia's Ministry of Health is limiting the sales of two more diabetes drugs in an attempt to curb their off-label ...

Lawmakers are trying to restore access to GLP-1 weight loss drugs, like Ozempic and Wegovy, after Ohio removed medical ...

Most policies still exclude weight-loss medications under general exclusions unless they are part of the treatment of a ...

The B.C. government is restricting the sales of two more diabetes drugs to people outside Canada amid rising demand for the ...

More than 40% of American's are obese, according to the Centers for Disease Control and Prevention (CDC). And the epidemic ...